1Nahrendorf M, Hu K, Fraccarollo D, et al. Time course of fight ventricular remodelling in rats with experimental myocardial infarction [ J ]. Am J Physiol Heart Circ Physiol, 2003,284( 1 ) : H241-H248.
2Ohnishi S, Yanagawa B, Tanaka K, et at. Transplanatation of mesenchymal stem ceils attenuates myocardial injury and dysfunction in a rat model of acute myocarditis[ J]. J Mol Cell Cardiol,2007,42( 1 ) : 88-97.
3Nakamura Y, Wang X, Xu C, et al. Xenotransplantation of long-term-cultured swine bone marrow-derived mesenehymal stem cells [J].Stem Cells, 2007,25 (3) :612-620.
4Nicholas F, Grigoropoulo S, Mathur A, et al. Stem cells in cardiac repair[J]. Curt Opin Pharmacol, 2006,1 (6) 169-175.
5Toma C, Pettenger MF, Cahill KS, et al. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart[J].Circulation,2002,105(3) :93-98.
6Wang JS, Shum-Tim D, Chedrawy E, et al. The coronary- delivery of marrow stromal cells for myocardial regeneration:pathophysiologic and therapeutic implications[J]. J Thorac Cardiovasc Surg, 2001,122(4) : 699-705.
7Matsumoto R, Omura T, Yoshiyama M, et al. Vascular endothelial growth factor-expressing mesenchymal stem cell transplantation for the treatment of acute myocardial infarction[J]. Arterioscler Thromb Vasc Biol, 2005,25 (6) : 1 168- 1 173.
8Virag JI, Murry CE. Myofibroblast and endothelial cell proliferation during murine myocardial infarct repair [J]. Am J Pathol, 2003,163 (6) : 2 433-2 444.
9Kamihata H, Matsubara H, Nishiue T, et al. Improvement of collateral perfusion and regional funetion by implantation of peripheral blood mononuclear cells into isehemie hibernating myocardium[J]. Arterioscler Thromb Vasc Biol,2002,22(11):1 804-1 810.
4[2]Werneck-de-Castro JP,Costa-E-Sousa RH,de Oliveira PF,et al.G-CSF does not improve systolic function in a rat model of acute myocardial infarction.Basic Res Cardiol,2006,101(6):494-501.
5[3]Li RK,Mickle DA,Weisel RD,et al.Optimal time for cardiomyocyte transplantation to maximize myocardial function after left ventricular injury.Ann Thorac Surg,2001,72(6):1957-1963.
6[4]Collby C,McAfee SL,Finkelstein DM,et al.Early vs delayed administration of G-CSF following autologous peripheral blood stem cell transplantation.Bone Marrow Transplant,1998,21(10):1005-1010.
7[5]Frangogiannis NG,Smith CW,Entman ML.The inflammatory response in myocardial infarction.Cardiovasc Res,2002,53(1):31-47.
8[6]Li J,Brown L F,Hibberd MG,et al.VEGF,flk-1,and flt-lexpression in a rat myocardial infarction model of angiogenesis.Am J Physiol,1996,270(5 Pt 2):H1803-1811.
9Makino S, Fukuda K, Miyoshi S, et al. Cardiomyocytes can be generated from marrow stromal cells in vitro. J Clin Invest 1999, 103:697 -705.
10Tomita S, Mickle D, Weisel RD, et al. Improved heart function with myogenesis and angiogenesis after autologous porcine bone marrow stromal cell transplantation. J Thorac Cardiovasc Surg. 2002; 123(6): 1132 -40.
4Zimmermann WH,Melnychenko I,Wasmeier G. Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts[J].{H}Nature Medicine,2006,(04):452-458.
5Leor J,Patterson M,Quinones MJ. Transplantation of fetal myocardial tissue into the infarcted myocardium of rat.A potential method for repair of infarcted myocardium[J].{H}CIRCULATION,1996,(9 Suppl):II332-II336.
6Leor J,Aboulafia-Etzion S,Dar A. Bioengineered cardiac grafts:A new approach to repair the infarcted myocardium[J].{H}CIRCULATION,2000,(19 Suppl 3):III56-III61.
7鄂征.组织培养和分子细胞学技术[M]{H}北京:北京出版社,199556.
8Le Coz F,Funck-Brentano C,Morel T. Pharmacokinetic and pharmacodynamic modeling of the effects of oral and intravenous administrations of dofetilide on ventricular repolarization[J].{H}Clinical Pharmacology & Therapeutics,1995,(05):533-542.
9Fink C,Ergün S,Kralisch D. Chronic stretch of engineered heart tissue induces hypertrophy and functional improvement[J].{H}FASEB JOURNAL,2000,(05):669-679.
10Zimmermann WH,Schneiderbanger K,Schubert P. Tissue engineering of a differentiated cardiac muscle construct[J].{H}CIRCULATION RESEARCH,2002,(02):223-230.
